settings, with some evidence of declining service provision post MSF hand-over. The main 5.2 Scaling-up coverage contribution of the project however has been its demonstration of proof of concept which (Additional number of people who benefit from has helped set the stage for longer term scalability of routine VL monitoring. a better health product or approach)
settings, with some evidence of declining service provision post MSF hand-over. The main contribution of the project however has been its demonstration of proof of concept which has helped set the stage for longer term scalability of routine VL monitoring. 5.2 Scaling-up coverage (Additional number of people who benefit from a better health product or approach)
CEPA-evaluation-report_UNITAID-MSF-Grant-20180529_FINAL.docx